EnteroMedics is a development-stage medical device company focused on the development of neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal issues. EnteroMedics’ VBLOC® vagal blocking therapy is a unique, broadly patented therapeutic approach designed to treat a range of gastrointestinal and metabolic diseases. VBLOC Therapy is a first-in-class weight loss treatment designed to help address the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension.  For more information visit the company’s Web site at www.enteromedics.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: